ACE2 and COVID-19: Flow cytometry analysis with an eight-color immunophenotyping panel showed that both primary CD4+ and CD8+ T cells derived from a patient with severe COVID-19 had the highest cell surface LSD1–ACE2 co-expression, followed by lower expression in moderate disease and even lower expression in mild disease (Fig. 3a).